MENU
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fate Therapeutics (FATE) Earnings Date & Reports
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
FATE is expected to report earnings to rise 4.88% to -27 cents per share on October 29
Q3'26
Est.
$-0.27
Q1'26
Beat
by $0.02
Q4'25
Est.
$-0.27
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -28 cents. With 2.49M shares outstanding, the current market capitalization sits at 326.37M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com